Nidan Laboratories and Healthcare Inkomsten in het verleden
Verleden criteriumcontroles 0/6
Nidan Laboratories and Healthcare has been growing earnings at an average annual rate of 1.3%, while the Healthcare industry saw earnings growing at 29.2% annually. Revenues have been growing at an average rate of 2.4% per year.
Belangrijke informatie
1.3%
Groei van de winst
-2.1%
Groei van de winst per aandeel
| Healthcare Groei van de industrie | 29.4% |
| Inkomstengroei | 2.4% |
| Rendement op eigen vermogen | -4.9% |
| Nettomarge | -13.4% |
| Laatste winstupdate | 31 Mar 2024 |
Recente prestatie-updates uit het verleden
Opbrengsten en kosten
Hoe Nidan Laboratories and Healthcare geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
| Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
|---|---|---|---|---|
| 31 Mar 24 | 242 | -32 | 49 | 0 |
| 31 Dec 23 | 231 | 0 | 51 | 0 |
| 30 Sep 23 | 220 | 31 | 53 | 0 |
| 30 Jun 23 | 231 | 33 | 52 | 0 |
| 31 Mar 23 | 243 | 35 | 52 | 0 |
| 31 Dec 22 | 257 | 34 | 48 | 0 |
| 30 Sep 22 | 272 | 32 | 43 | 0 |
| 30 Jun 22 | 289 | 27 | 39 | 0 |
| 31 Mar 22 | 297 | 27 | 39 | 0 |
| 31 Mar 21 | 208 | 23 | 28 | 0 |
| 31 Mar 20 | 222 | 7 | 42 | 0 |
| 31 Mar 19 | 206 | 2 | 40 | 0 |
Kwaliteitswinsten: NIDAN is currently unprofitable.
Groeiende winstmarge: NIDAN is currently unprofitable.
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: NIDAN is unprofitable, but has reduced losses over the past 5 years at a rate of 1.3% per year.
Versnelling van de groei: Unable to compare NIDAN's earnings growth over the past year to its 5-year average as it is currently unprofitable
Winst versus industrie: NIDAN is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (30.6%).
Rendement op eigen vermogen
Hoge ROE: NIDAN has a negative Return on Equity (-4.88%), as it is currently unprofitable.